Log in
FREE 15-Day Trial
Intelligent Investor
Intelligent Investor
  1. Home
  2. Research & Advice
  3. Research Tools
  4. Shares
  5. Burgundy Diamond Mines Limited (BDM)
  6. Company Announcements

Burgundy Diamond Mines Limited (ASX: BDM) - Announcements

Current share price for BDM : $0.170 0.01 (5.56%)

ASX company news and announcements for Burgundy Diamond Mines Limited (BDM) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Burgundy Diamond Mines Limited (BDM) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Burgundy Diamond Mines Limited (BDM), please use our Company Announcements tool to search across all ASX-listed companies.

Intelligent Investor free trial for buy hold sell stock recommendations

Latest company announcements for Burgundy Diamond Mines Limited (BDM)

Search all Announcements
Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg		 Gain/Loss
$242 Disclosure Document 7 Aug 2006 10:08AM $0.261 $0.170 $0.185 fallen by 34.94%
$242 Proposed two for three entitlement issue 7 Aug 2006 10:01AM $0.261 $0.170 $0.185 fallen by 34.94%
$242 Commitments Test Entity - Fourth Quarter Report 27 Jul 2006 2:35PM n/a $0.170 $0.185 n/a
$242 First patients complete BDM-E phase II study 17 Jul 2006 10:19AM $0.271 $0.170 $0.185 fallen by 37.20%
$242 Moves into commercialisation phase for BDM-I feed additive 14 Jul 2006 10:17AM $0.271 $0.170 $0.185 fallen by 37.20%
$242 Response to ASX Query re: Appendix 4C 2 May 2006 6:20PM $0.420 $0.170 $0.185 fallen by 59.52%
$242 Commitments Test Entity - Third Quarter Report 27 Apr 2006 2:21PM $0.439 $0.170 $0.185 fallen by 61.25%
$242 Results in recent feed additive trials for BDM-1 6 Apr 2006 10:36AM $0.495 $0.170 $0.185 fallen by 65.64%
$242 Commences Clinical Trial for Diabetic Eye Disease 1 Mar 2006 11:58AM $0.681 $0.170 $0.185 fallen by 75.05%
$242 Half Yearly Report 1 Mar 2006 9:16AM $0.681 $0.170 $0.185 fallen by 75.05%
$242 Commitments Test Entity - Second Quarter Report 25 Jan 2006 4:12PM $0.602 $0.170 $0.185 fallen by 71.76%
$242 Wins $2m AusIndustry Grant Award 21 Dec 2005 9:43AM $0.700 $0.170 $0.185 fallen by 75.71%
$242 Clinical Trial in Diabetic Eye Disease 1 Dec 2005 12:35PM $0.625 $0.170 $0.185 fallen by 72.81%
$242 BioDiem receives 3rd Milestone of US$1m for Flu Vaccine 29 Nov 2005 9:36AM $0.663 $0.170 $0.185 fallen by 74.34%
$242 Commitments Test Entity - First Quarter Report 20 Oct 2005 4:02PM $0.761 $0.170 $0.185 fallen by 77.65%
$242 Preliminary Final Report 25 Aug 2005 3:01PM $0.560 $0.170 $0.185 fallen by 69.64%
$242 BioDiem receives 2nd milestone 29 Jul 2005 9:44AM $0.467 $0.170 $0.185 fallen by 63.57%
$242 Commitments Test Entity - Fourth Quarter Report 29 Jul 2005 9:42AM $0.467 $0.170 $0.185 fallen by 63.57%
$242 BioDiem Exercises Option 27 Sep 2004 9:28AM $0.607 $0.170 $0.185 fallen by 71.98%
$242 Pre-clinical Results Show Potential of New Avian Flu Vaccine 15 Apr 2004 10:14AM $0.831 $0.170 $0.185 fallen by 79.53%
$242 Pre-clinical Results Show Potential of New Avian Flu Vaccine 15 Apr 2004 10:14AM $0.831 $0.170 $0.185 fallen by 79.53%
$242 Half Yearly Report 25 Feb 2004 4:01PM $0.840 $0.170 $0.185 fallen by 79.76%
$242 Half Yearly Report 25 Feb 2004 4:01PM $0.793 $0.170 $0.185 fallen by 78.57%
$242 Gains approval for US Patent on eye compound 10 Feb 2004 9:51AM $0.924 $0.170 $0.185 fallen by 81.60%
$242 Admission to Official List 27 Jan 2004 5:39PM n/a $0.170 $0.185 n/a

326 - 350 of 350 results

Page 14 of 14

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.